Not surprisingly, 9 days’ APR treatment with AD differentiation strongly inhibited adipocyte formation (Figure 6F, G) and the expression of PPARγ2, CEBP/α and LPL (Figure 6 H, I) in ADSCs. The gene discussed is LPL; the disease is Alzheimer disease.